International Journal of Tropical Medicines
Volume 3, Issue 2 (2026)
Table of contents
-
"Onychomycosis in the Indian Subcontinent: Clinical, Microbiological and Therapeutic Perspectives,”
Abstract: Onychomycosis is a chronic fungal infection of the nail unit involving the plate, bed, and matrix, accounting for a substantial proportion of nail disorders encountered in dermatology practice worldwide. In South Asia—particularly India, Pakistan, Bangladesh, and Nepal—the burden is amplified by a convergence of climatic, socioeconomic, and healthcare-related factors. Hot and humid environmental conditions, widespread dermatophytosis, occlusive footwear practices, chronic wet work, and limited access to specialized mycological diagnostics contribute …
Published in International Journal of Tropical Medicines · Vol. 3, Issue 2, 2026 Read article
-
Reward-Aligned Reinforcement Learning from Human Feedback for Emotion-Sensitive Large Language Model Therapists: Balancing Empathetic Engagement, Boundary Safety, and Clinical Accountability
Abstract: The deployment of large language models (LLMs) in mental health therapy contexts introduces a critical alignment challenge: these systems must simultaneously cultivate genuine empathic rapport, observe clinically grounded safety boundaries, and remain auditable under institutional accountability frameworks. Existing reinforcement learning from human feedback (RLHF) pipelines optimize for a scalar reward signal that is demonstrably insufficient for the multi-objective, temporally extended nature of therapeutic conversation. This paper presents RA-RLHF-T (Reward-Aligned RLHF …
Published in International Journal of Tropical Medicines · Vol. 3, Issue 2, 2026 Read article
-
Drug Marketing in Tropical Regions and Its Effect on Pharmacovigilance Awareness and Reporting
Abstract: Drug marketing practices in tropical regions present a complex interplay between pharmaceutical promotion, healthcare infrastructure limitations, and public health outcomes. These regions – characterized by high disease burden, socio-economic disparities, and diverse healthcare delivery systems – often experience unique challenges in ensuring safe and rational drug use. Aggressive and sometimes unregulated marketing strategies by pharmaceutical companies may significantly influence prescribing behavior, patient compliance, and, ultimately, pharmacovigilance systems. Pharmacovigilance, defined as …
Published in International Journal of Tropical Medicines · Vol. 3, Issue 2, 2026 · pp. 1–17 Read article